Tetra Bio Pharma
高管
查看带有其 9 名主要高管的组织结构图
Tetra Bio Pharma 搜索最多的简介
- Guy Chamberland, Chief Executive Officer and and Chief Regulatory ...
- Brent Norton, Chairman of the Board
- John Kim, Director
创建提醒
跟踪 Tetra Bio Pharma 的高管变动
生物技术
Tetra Bio Pharma 拥有 2,317 家竞争者，其中包括 Eurofins (卢森堡)、Lonza (瑞士) 和 Biogen (美国(美洲))。
Popular M&A news in 生物技术
- AgomAb Therapeutics 刚刚宣布为 89 筹款数百万美元。 (公布2024十月29号).
- Seaport Therapeutics 刚刚宣布为 225 筹款数百万美元。 (公布2024十月25号).
- TuHura Biosciences and Kintara Therapeutics have merged (公布2024十月20号)..
生物技术 行业的其他推荐联系人
消息
Tetra Bio Pharma 的最新新闻稿
- Tetra Bio-Pharma - Login
- Tetra Bio-Pharma Cancels New Drug Submission to Health Canada
- Tetra Bio-Pharma Announces Health Canada Authorization to Proceed with its Oral ARDS-003 New Drug in Human Trial
- Tetra Bio-Pharma Announces Cease Trade Order
- Tetra Bio-Pharma Receives Funding from the Government of Canada for ARDS-003
- Tetra Bio-Pharma Inc. Announces a Delay in Filing 2022 Annual Financial Statements and Related Management's Discussion and Analysis
- Tetra Bio-Pharma Announces Listing to OTCPink Market
- REDUVO™ Marketing Approval on the Right Path
- Tetra Bio-Pharma Announces Results of Artificial Intelligence Study of ARDS-003 Combined with Favipiravir
- Tetra Bio-Pharma Provides Update on Patent Applications for Novel Therapeutic ARDS-003
- View more press releases Close
通过电子邮件
